Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5847100 | 0.92 | ALDH1A1 (0.34) | ALDH1A1IDO1MEN1KMT2AGSTP1 | |
| SCHEMBL5696103 | 0.92 | ALDH1A1 (0.34) | ALDH1A1IDO1MEN1KMT2AGSTP1 | |
| SCHEMBL2720724 | 0.88 | ALDH1A1 (0.32) | ALDH1A1IDO1MEN1KMT2AGSTP1 | |
| SCHEMBL25277740 | 0.84 | ALDH1A1 (0.34) | ALDH1A1IDO1MEN1KMT2AGSTP1 | |
| SCHEMBL1097047 | 0.80 | ALDH1A1 (0.32) | ALDH1A1IDO1GSTP1 | |
| SCHEMBL4621793 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KMT2AGSTP1POLBHPGD | |
| SCHEMBL5845679 | 0.78 | ALDH1A1 (0.31) | ALDH1A1IDO1GSTP1 | |
| SCHEMBL21085574 | 0.78 | KMT2A (0.37) | ALDH1A1IDO1MEN1KMT2APOLB | |
| SCHEMBL1059333 | 0.78 | KMT2A (0.37) | ALDH1A1IDO1MEN1KMT2APOLB | |
| SCHEMBL20484797 | 0.78 | KMT2A (0.37) | ALDH1A1IDO1MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1882748-A2 | A population of nucleic acids including a subpopulation of LNA oligomers | Exiqon A/S (DK) | 2008-01-30 | — | — | EP | disclosed |
| US-20060147924-A1 | Population of nucleic acids including a subpopulation of lna oligomers | EXIQON A/S (DK) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060147924-A1 | Population of nucleic acids including a subpopulation of lna oligomers | NSUN2, NCL, RNGTT | ALDH1A1 2855/4885IDO1 3100/4885MEN1 3088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.